Regulatory Announcements

All regulatory news and announcements concerning MedPal AI will be archived here in accordance with AIM Rule 26. This section will include an up-to-date archive of the Company’s Regulatory News Service (RNS) releases and any other official market announcements, starting from the date of admission to the AIM market. Investors and stakeholders will be able to review all important company updates and disclosures from the last 12 months (and beyond) in one place.


Coming soon: an option to subscribe to email alerts for MedPal AI’s regulatory announcements will be provided, allowing interested parties to receive news updates directly.